Figures & data
Table 1. The design of the nine prepared formulae.
Figure 3. (a) Cumulative percentage release of ketorolac from the nine wafer formulations and (b) cumulative percentage release of lidocaine from the nine wafer formulations.
![Figure 3. (a) Cumulative percentage release of ketorolac from the nine wafer formulations and (b) cumulative percentage release of lidocaine from the nine wafer formulations.](/cms/asset/a6b29c33-e9d2-45de-b2c0-6b2941b94918/idrd_a_1413445_f0003_c.jpg)
Table 2. Ex vivo mucoadhesive time of the nine tested drug formulations.